OTC Topical Cream Cartons May Contain Mislabeled Prescription Toothpaste
Capsaicin Cream 0.025% cartons labeled as pain relief cream may contain Sodium Fluoride 1.1% prescription dental toothpaste instead. Consumers should verify product contents before use.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses, hospitalizations, or injuries. The hazard is a product mix-up where mislabeled cartons may contain a prescription dental toothpaste instead of the labeled topical analgesic, creating a risk of harm if misused, but with no actual adverse events reported.
Plain-English summary
Capsaicin Cream 0.025% manufactured by AVKARE LLC is being recalled due to a product mix-up. Some cartons labeled as Capsaicin Cream 0.025%, an external analgesic cream for topical pain relief, may actually contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste.
The affected product involves Lot # P22078 (expiration date 11/30/2024) distributed to 19 consignees across the United States. A total of 35,184 cartons are affected.
If you have purchased Capsaicin Cream 0.025% from this lot, verify that the actual product contents match the label before using it. Do not apply prescription dental toothpaste to your skin. Contact AVKARE LLC or your retailer with questions about whether you have affected product.
The recalled product
- Product
- CAPSAICIN (CAPSAICIN)
- Brand
- CAPSAICIN
- Manufacturer
- AVKARE LLC
- Category
- Drug — Topical Analgesic
- Hazard
- product-mix-up
- mislabeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # P22078
- Exp. 11/30/2024
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27